Anaesthesia application modes compared

Article

Contact anaesthesia is just as safe and effective as peribulbar application for combined cataract and glaucoma surgery, according to study results published online ahead of print by Ophthalmologica.

Contact anaesthesia is just as safe and effective as peribulbar application for combined cataract and glaucoma surgery, according to study results published online ahead of print by Ophthalmologica.

Luis E. Pablo of the Department of Ophthalmology at Miguel Servet University Hospital, Zaragoza, Spain and colleagues conducted a randomized study of patients undergoing phacotrabeculectomy (n=120), assessing pain, complications and success of surgery and comparing the results obtained by patients receiving topical contact anaesthesia with those obtained from peribulbar anaesthesia injection.

The team found that peribulbar injection was associated with more pain than topical anaesthesia at the time of application; during and after surgery, however, there was no difference in the levels of pain experienced by the separate groups. In terms of both tension and visual acuity, there was again no difference between the groups treated with the different application methods.

Therefore the researchers concluded that, during surgery and in the mid- to long-term, topical anaesthesia application and peribulbar application are associated with similar outcomes and levels of pain.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.